Product features

Inactivated Epstein Barr virus (EBV) formulated in human plasma specimen.

  • External quality control for nucleic acids detection
  • Validation of the complete analytical process: extraction & amplification
  • Complete inactivated microorganism in a matrix
  • Quantified controls (low positive)
  • 10 single-use lyophilized vials 

 

> Further information available for the design of primers and probes: 
· Complete genome:Epstein-Barr virus V01555.2

Kit AMPLIRUN TOTAL

PRODUCTS

AMPLIRUN® TOTAL EBV CONTROL (PLASMA)

RUO
Inactivated Epstein Barr virus (EBV) formulated in human plasma specimen and intended to validate and control sample processing, analysis and detection in nucleic acid assays using the product as an external run control.

Analytes: Epstein-Barr

Reference MBTC019-R
Pack size 10 vials
Volume 200 μL

HOW IT WORKS

amplirun total how does it work

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

H. pylori stool antigen testing: when the test works, but the workflow no longer does
21 September 2026

H. pylori stool antigen testing: when the test works, but the workflow no longer does

Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
10 August 2026

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
31 July 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...